Search
forResearch 10 of 1000+
- Identification of drug-specific public TCR driving severe cutaneous adverse reactions
- Cutaneous adverse reactions linked to targeted anticancer therapies bortezomib and lenalidomide for multiple myeloma: new drugs, old side effects
- Cutaneous Adverse Reactions to IL-17 and IL-23 Inhibitors: A Clinical Review of Reaction Patterns
- Cutaneous adverse reactions associated with enfortumab vedotin: a pharmacovigilance study based on the FDA adverse event reporting system
- Spontaneous cutaneous adverse drug reaction reports—An analysis of a 10‐year dataset in Singapore
- Incidence of adverse cutaneous drug reactions in a Mexican sample: an exploratory study on their association to tumour necrosis factor alpha TNF2 allele
- Cutaneous Adverse Drug Reactions (CADRs) to COVID19 vaccines: A case series
- Cutaneous adverse drug reaction associated with topical use of benzyl benzoate in a dog
- Cutaneous Adverse Drug Reactions to Antibiotics: How Much is the Extent of the Problem?
- A clinical study of cutaneous adverse drug reactions
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →